检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

OVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with bevacizumab

Melissa M. Hardesty,Thomas C. Krivak,Gail S. Wright,Erika Hamilton,Evelyn L. Fleming,Jimmy Belotte,Erika K. Keeton,Ping Wang,Divya Gupta,Aine Clements,Heidi J. Gray,Gottfried E. Konecny,Richard G. Moore,Debra L. Richardson

Gynecologic Oncology（2022）

引用 19|浏览9
暂无评分
摘要
Unlabelled Image
更多
查看译文
关键词
PARP,Niraparib,Ovarian cancer,Advanced,VEGF,Bevacizumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要